Cutaneous Oncology News

The addition of atezolizumab to cobimetinib and vemurafenib significantly prolonged PFS and conferred durable responses among patients with BRAF V600 mutation-positive advanced melanoma, according to results of the randomized phase 3 IMspire150 study presented at the virtual American Association for Cancer Research Annual Meeting.

Patients with facial skin cancers appeared to have unrealistic expectations regarding scarring after Mohs micrographic surgery, according to results of prospective, cross-sectional study published in JAMA Network Open.

A predominance of host-associated risk factors compared with transplant-associated risk factors has been identified in association with the development of keratinocyte carcinoma after allogeneic hematopoietic cell transplant, according to a study published in JAMA Dermatology.

Personalized music may be a viable option for reducing perioperative anxiety in patients undergoing Mohs micrographic surgery, but more data are needed to determine its effects, according to a systematic review.

Melanoma incidence rates differ between men and women by age and anatomic site in predominantly fair-skinned populations, according to a cross-sectional analysis published in JAMA Dermatology.

Three-quarters of patients would recommend artificial intelligence as a component of clinical decision-making for skin cancer, according to a survey.

The introduction and approval of new treatments for metastatic melanoma has led to significant declines in population-level mortality over the past several years, according to results of a retrospective study published in American Journal of Public Health.

A phase 3 trial designed to evaluate SGX301 for treatment of cutaneous T-cell lymphoma met its primary endpoint, according to the agent’s manufacturer.

About three-quarters of patients with advanced melanoma who achieved complete responses to single-agent anti-PD-1 therapy remained in remission at 3 years, according to results of a single-center retrospective study published in Journal of Clinical Oncology.

Uncommon variants of cutaneous melanoma do not have the classic clinical appearance and dermoscopic criteria for diagnosis, according to a systematic review published in JAMA Dermatology.